Emil E. Hassan, serving as a director for National Healthcare Corp (NASDAQ:NHC), completed a transaction on June 16, 2026, involving the sale of 1,563 shares of the company's common stock. The execution price for these shares was $199.975, generating total proceeds of approximately $312,560. This divestment occurs while the stock is trading near its 52-week high of $205.06, a level reached after the stock delivered an 84% return over the preceding year. According to InvestingPro analysis, the stock may currently be overvalued relative to its Fair Value, a factor that could have informed the director's decision to reduce his position.
Following the transaction, Mr. Hassan's direct ownership of National Healthcare common stock stands at 71,532 shares. The filing also outlines Mr. Hassan's holdings of options to purchase common stock, which remain unchanged. These holdings include 7,500 options from a 2022 grant with an exercise price of $69.19, 7,500 options from a 2023 grant with an exercise price of $55.75, 7,500 options from a 2024 grant with an exercise price of $96.03, 7,500 options from a 2025 grant with an exercise price of $94.66, and 7,500 options from a 2026 grant with an exercise price of $171.42. Each of these option grants represents the right to purchase 7,500 shares of common stock.
In other corporate developments, National HealthCare Corporation has finalized the purchase of five skilled nursing facilities for $50.5 million. This acquisition includes four facilities in Tennessee and one in South Carolina, adding 566 operating beds and granting NHC full ownership of both operations and real estate. Additionally, NHC has entered into an agreement to acquire 35 senior care facilities for $560 million from National Health Investors, Inc. While NHC will continue to operate most of these facilities, four Florida skilled nursing facilities will remain under a third-party operator's lease.
Regarding governance, NHC shareholders re-elected Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams to the board of directors for three-year terms during the recent annual meeting. Meanwhile, National Healthcare Properties Inc., a related entity, is experiencing strong interest in its initial public offering. Orders are coming in at $12 per share, which is below the initial marketed range. Despite the lower price, the offering is multiple times oversubscribed, indicating robust demand from investors.